跳至主要内容
临床试验/CTRI/2023/01/048802
CTRI/2023/01/048802已完成未知

Evaluation of dermatological safety of investigational products by 24hrs patch test under complete occlusion on Adult Healthy Human Participants.

nilever Industries Pvt Ltd0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Participants in age group 18 - 65 years (both the ages inclusive).
  • 2. Healthy male & female participants with skin types as defined in the population.
  • 3. Participants in good health condition as per the medical screening criteria with no disease state or physical condition that the Investigator believes could interfere with the interpretation of the data.
  • 4. Participants of any skin type providing the skin pigmentation will allow discernment of erythema
  • 5. Participants able to read, understand and sign an appropriate informed consent form indicating her willingness to participate.
  • 6. Participants willing to give a voluntary written informed consent.
  • 7. Participants willing to maintain the patch in position for 24 hours.
  • 8. Participants having not participated in a similar investigation in the past two weeks.
  • 9. Participants willing to come for regular follow up visits.
  • 10. Participants ready to follow instructions during the study period.

排除标准

  • 1. Participants with infection, allergy, psoriasis and/or active atopic dermatitis/eczema on the tested area.
  • 2. Athletes and participants with history of excessive sweating.
  • 3. Participants with cutaneous disease which may influence the study result.
  • 4. Participants on oral corticosteroid.
  • 5. Participants participating in any other cosmetic or therapeutic trial or have participated in a similar investigation in the past two weeks.
  • 6. Participants who are currently pregnant or lactating or planning to become pregnant in the period of study.
  • 7. Participants with any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.
  • 8. More than one participant selected/participating from one family/household.
  • 9. Participants working with MSCR

研究者

发起方
nilever Industries Pvt Ltd

相似试验